• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. LXC14; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. LXC14; ANTI-REFLUX IMPLANT Back to Search Results
Catalog Number LXC14
Device Problems Migration or Expulsion of Device (1395); Device Slipped (1584)
Patient Problem No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Date of event: only event year known: 2018.The lot was not provided; therefore, the manufacturing record evaluation could not be performed.
 
Event Description
It was reported that the patient had a magnetic sphincter augmentation device implanted for medically refractory gastroesophageal reflux.It was reported a reoccurrences of heartburn symptoms (moderate intensity).The follow-up egd that took place (b)(6) 2018 - impression that linx slipped onto the cardia of the stomach.Per dr.(b)(6), he doesn¿t believe it is definitive the device has moved.The device was removed on (b)(6) 2019 and a toupet fundoplication was done.The patient was discharged after a 33-hour hospital stay.
 
Manufacturer Narrative
(b)(4).Additional information was received: lxc14, lot 4477.Device analysis: overall review of the device function and dimensions show no anomalies from a device that has been reasonably changed as part of the explant procedure.Visual analysis was consistent with an explanted device, and link length and tensile force were found to meet the applicable specifications.Overall, no analysis conclusions relevant to the patient experience were found.The dhr for lot 4477 was reviewed.No ncs, defects, or reworks related to the product complaint were found.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).Additional information was received: interventions taken: office/clinic visit ((b)(6) 2018), egd ((b)(6) 2018), dilation ((b)(6) 2018), explant ((b)(6) 2019), surgical intervention ((b)(6) 2019).09may2019 update: reviewing the discharge note, all 14 beads were removed, and the subject was converted to a partial fundoplication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LXC14
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
MDR Report Key8599645
MDR Text Key144712869
Report Number3008766073-2019-00340
Device Sequence Number1
Product Code LEI
Combination Product (y/n)N
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup,Followup
Report Date 04/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/05/2017
Device Catalogue NumberLXC14
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer05/13/2019
Initial Date Manufacturer Received 04/23/2019
Initial Date FDA Received05/10/2019
Supplement Dates Manufacturer Received04/23/2019
05/14/2019
08/20/2019
Supplement Dates FDA Received05/14/2019
06/10/2019
09/16/2019
Patient Sequence Number1
Patient Age74 YR
-
-